REYON Pharmaceutical Co., Ltd. (KRX:102460)

Market Cap	221.93B
Revenue (ttm)	148.04B
Net Income (ttm)	4.04B
Shares Out	18.34M
EPS (ttm)	220.05
PE Ratio	54.99
Forward PE	n/a
Dividend	150.00 (1.24%)
Ex-Dividend Date	n/a

Volume	144,694
Average Volume	165,293
Open	12,880
Previous Close	13,750
Day's Range	12,500 - 12,900
52-Week Range	9,830 - 18,650
Beta	0.68
RSI	62.29
Earnings Date	Aug 14, 2025

About REYON Pharmaceutical

REYON Pharmaceutical Co., Ltd. manufactures and sells medicines. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; antibiotics; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1955
• Employees: 448
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 102460

Financial Performance

In 2024, REYON Pharmaceutical's revenue was 148.30 billion, a decrease of -1.83% compared to the previous year's 151.07 billion. Earnings were 4.15 billion, an increase of 15.85%.